Baker McKenzie Switzerland AG leverages its international network to assist clients with a broad range of issues, including licence and employment agreements, and clinical trail strategy. The practice is jointly led by Olha Demianiuk and Julia Schieber. Demianiuk has a great deal of expertise in multi-jurisdictional M&A and health product portfolio acquisitions. Noted for her ‘profound’ industry knowledge, Schieber primarily focuses on IP and IT related issues, including the exploitation of IP rights, and collaboration and R&D agreements. Matthias Courvoisier leads the firm’s capital markets team, acting in a number of public takeovers and IPOs.
Testimonials
Collated independently by Legal 500 research team.
‘Good people with knowledge, quick answers, always available.’
‘Very experienced and well connected.’
‘Well-researched and pragmatic advice across multiple jurisdictions.’
‘It is an absolute pleasure to work with Julia Schieber, she is a very fast thinker, provides business oriented, thoughtful and pragmatic advice and is an excellent thought partner on tricky issues. She has profound industry knowledge.’
Key clients
- Abbott
- Abbvie
- Actelion Pharmaceuticals AG
- Adagene AG
- Alexion
- Allecra Therapeutics AG
- Argenx SE
- Aricium
- Baitella Holding AG
- Basilea Pharmaceutica AG
- Bausch Health Corporation
- Baxalta Inc
- Baxter
- Becton Dickinson
- Bruker BioSpin
- Cassiopea SpA
- Celgene
- Cell Medica Ltd
- Cosmo Pharmaceutical NV
- CSL Behring Beteiligungs- und Verwaltungs GmbH & Co KG
- Curasept A.D.S. S.r.l.
- CureTeq AG
- CureVac AG
- DocMorris
- Galapagos
- Galderma
- GSK
- Implantica AG
- Mapreg SAS
- Medmix
- Mérieux Equity Partners
- Moderna
- Novaliq
- Novartis
- Numab
- OnlineDoctor
- Sandoz
- Sanofi Aventis (Suisse) SA
- Similasan
- Sonova AG
- Takeda
- The International Federation of Pharmaceutical Manufacturers & Associations
- Zur Rose Group
Work highlights
- Advised GSK plc in a license agreement with WuXi Biologics under which GSK will have exclusive licenses for up to four bi- & multi-specific TCE antibodies developed using WuXi Biologics’ proprietary technology platforms.
- Advising BD Switzerland Sàrl on various employment matters , including review of employment agreements and assistance in relation to termination of employees.
Lawyers
Practice head
The lawyer(s) leading their teams.
Olha Demianiuk, Julia Schieber